October 23, 2016 4:49 PM ET


Company Overview of Azelon Pharmaceuticals, Inc.

Key Executives for Azelon Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Kari Watson No RelationshipsVice President--

Azelon Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Farah H. Champsi 70 RelationshipsAlta Partners LP55
Brian MacDonald MB, ChB, Ph.D. 14 RelationshipsAzelon Pharmaceuticals, Inc.--
Colin Goddard Ph.D. 88 RelationshipsCoferon, Inc.56
Claude D. Arnaud M.D. 18 RelationshipsImaging Therapeutics, Inc.86
Steven Cummings 14 RelationshipsAzelon Pharmaceuticals, Inc.--
View All Board Members

Azelon Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Azelon Pharmaceuticals, Inc. CEO Compensation
Industry Average


Cynapsus Therapeutics Inc. Announces Management Changes
October 21, 2016 9:26 PM ET
Mark L. Thompson to Step Down as Chief Executive Officer and Chairman of Concordia International Corp
October 21, 2016 5:55 PM ET
Dechra Pharmaceuticals plc Announces Executive Changes
October 21, 2016 6:00 AM ET
Scot L. Harper, Vice President of Clinical Operations, to Leave Endocyte, Inc., Effective October 28, 2016
October 20, 2016 8:30 PM ET
Endo International plc Announces Executive Changes, Effective November 22, 2016
October 20, 2016 8:05 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Azelon Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.